Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVIDENT-HPV video intervention trial for catch-up HPV vaccination
jRCT1030230315Recruiting
- Start
- Aug 2023
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of Walrinvax in Cervical Cancer (CC) (2 arms), sponsored by None. Primary endpoint: Catch-up HPV vaccination rate. Started Aug 2023; status: recruiting.
02
Drugs
Walrinvax
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on jRCT1030230315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1030230315.